Categories · Health/Science
· Business (Tobacco)
· Secret Documents
· Secondhand Smoke
· Cardio-vascular
· Ethics
· Philanthropy/Funding
|
(Circulation. 2007;116:1845-1854.) Volume 116, Issue 16; October 16, 2007 Jump to full article: Circulation, 2007-10-16 Author: Elisa K. Tong, MD, MA; Stanton A. Glantz, PhD
Intro: Conclusions— The tobacco industry attempted to undermine the evidence that SHS causes CVD to fight smoke-free regulations while developing approaches to support new products that claim to reduce harm. The industry interest in preserving corporate viability has affected the design and interpretation of their cardiovascular studies, indicating the need for great caution in current debates about future tobacco industry regulation and development of reduced-harm tobacco products.
Jump to full article » |